Estrella Immunopharma, Inc. (ESLA) stock
ESLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLAW
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.33−0.05 (-12.74%)
Close on Nov 17, 2026Market cap $14.42MP/E –Yield –
Estrella Immunopharma total assets
Total assets on the balance sheet at the end of each period.
Estrella Immunopharma's total assets was $1.82M at Jun 30, 2026. For fiscal 2024 it was $4.45M, down 90.3% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $4.45M | -90.3% |
| FY2021 | Dec 31, 2021 | $45.80M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026CQ3 2025 | Jun 30, 2026 | $1.82M | -93.3% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $4.45M | -90.3% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $8.63M | -81.2% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $9.45M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $27.35M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $45.80M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $45.97M | – |
See a number that looks wrong?